World Health Organization
WHO recommends two monoclonal antibody treatments for Ebola
WHO has recommended two monoclonal antibody treatments for Ebola virus disease.
Transplantation within 7 days of listing boosts survival in acute-on-chronic liver failure
LONDON — Early liver transplantation within 7 days of listing was linked to improved 90-day and 1-year survival among patients with grade 3 acute-on-chronic liver failure, according to data presented at the International Liver Congress.
WHO: HCV elimination by 2030 demands ‘scale-up, simplification’ of care pathways
LONDON —WHO presented updated guidance on hepatitis C, calling for drastic simplification of care pathways to alleviate access gaps in HCV testing and treatment, during a joint WHO-EASL-CDC symposium at the International Liver Congress.
Innovation can address ‘profound inequality’ in cancer care, ASCO keynote speaker says
CHICAGO — The keynote speaker at ASCO Annual Meeting urged attendees to focus on social and organizational innovations that can advance equity in cancer care.
Low-cost scoring system informs HBV treatment eligibility in resource-limited countries
SAN DIEGO — A new, low-cost scoring system called TREAT-B accurately determined treatment eligibility for patients with hepatitis B virus, particularly where DNA assays are unavailable, according to research.
Hepatitis Awareness Month: acute hepatitis in children, WHO guidance and more
May is Hepatitis Awareness Month, and the CDC and its public health partners are raising awareness and encouraging increased screening and vaccination.
COVID-19 associated with nearly 15 million excess deaths, WHO finds
Nearly 15 million people died as a direct or indirect result of COVID-19 during the first 24 months of the pandemic, according to a new estimate published Thursday by WHO.
Q&A: ‘The search for answers continues,’ expert says about hepatitis outbreak in children
As the WHO continues its investigation into an outbreak of severe, acute hepatitis of unknown origin in children aged 1 month to 16 years, more questions than answers remain.
WHO recommends Paxlovid for patients with non-severe COVID-19
WHO has announced that it strongly recommends administering Pfizer’s Paxlovid to patients with non-severe COVID-19 who are at highest risk for hospitalization.
WHO pediatric tumor classification reflects transition to molecular diagnosis
A first-ever pediatric blue book has been developed as part of the fifth edition of the WHO Classification of Tumors series.